Silvia Ferrati

1.1k total citations
32 papers, 918 citations indexed

About

Silvia Ferrati is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Silvia Ferrati has authored 32 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 12 papers in Molecular Biology and 10 papers in Biomaterials. Recurrent topics in Silvia Ferrati's work include Nanoparticle-Based Drug Delivery (9 papers), Microfluidic and Capillary Electrophoresis Applications (9 papers) and Nanopore and Nanochannel Transport Studies (7 papers). Silvia Ferrati is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Microfluidic and Capillary Electrophoresis Applications (9 papers) and Nanopore and Nanochannel Transport Studies (7 papers). Silvia Ferrati collaborates with scholars based in United States, Italy and Chile. Silvia Ferrati's co-authors include Mauro Ferrari, Hugh D. C. Smyth, Rita E. Serda, Alessandro Grattoni, Xuewu Liu, Ashlee D. Brunaugh, Erika Zabre, Biana Godin, Shyam S. Bansal and Sharath Hosali and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

Silvia Ferrati

32 papers receiving 909 citations

Peers

Countries citing papers authored by Silvia Ferrati

Since Specialization

Citations

This map shows the geographic impact of Silvia Ferrati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Ferrati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Ferrati more than expected).

Fields of papers citing papers by Silvia Ferrati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Ferrati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Ferrati. The network helps show where Silvia Ferrati may publish in the future.

Co-authorship network of co-authors of Silvia Ferrati

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Ferrati. A scholar is included among the top collaborators of Silvia Ferrati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Ferrati. Silvia Ferrati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms 2018 ·Journal of Pharmaceutical Sciences ·(unknown), Silvia Ferrati, (unknown), Hugh D. C. Smyth	2
2	Dosing considerations for inhaled biologics 2018 ·International Journal of Pharmaceutics ·Silvia Ferrati, Tian Wu, (unknown), Hugh D. C. Smyth	21
3	Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach 2018 ·AAPS PharmSciTech ·Silvia Ferrati, Tian Wu, (unknown), Ashlee D. Brunaugh, (unknown), Hugh D. C. Smyth	22
4	The Display of Single-Domain Antibodies on the Surfaces of Connectosomes Enables Gap Junction-Mediated Drug Delivery to Specific Cell Populations 2017 ·Biochemistry ·Avinash K. Gadok, Chi Zhao, (unknown), Silvia Ferrati, (unknown), Janet Zoldan, Hugh D. C. Smyth, Jeanne C. Stachowiak	12
5	Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes 2017 ·The AAPS Journal ·Javier Morales, Kristin Fathe, Ashlee D. Brunaugh, Silvia Ferrati, Song Li, (unknown), (unknown), Jason T. McConville, Mark R. Prausnitz, Hugh D. C. Smyth	112
6	Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet Micronization 2017 ·Molecular Pharmaceutics ·Ashlee D. Brunaugh, Syed Umer Jan, Silvia Ferrati, Hugh D. C. Smyth	40
7	Inhaled Biologics: From Preclinical to Product Approval 2016 ·Current Pharmaceutical Design ·Kristin Fathe, Silvia Ferrati, (unknown), (unknown), Hugh D. C. Smyth	17
8	Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System 2015 ·Current Drug Targets ·Silvia Ferrati, (unknown), Shyam S. Bansal, Sharath Hosali, Melissa D. Landis, Alessandro Grattoni	30
9	The Nanochannel Delivery System for Constant Testosterone Replacement Therapy 2015 ·The Journal of Sexual Medicine ·Silvia Ferrati, (unknown), Erika Zabre, (unknown), Beverly A. Shirkey, Hudson Lee, Sharath Hosali, Michael J. Crawley, Mohit Khera, Ganesh S. Palapattu, Alessandro Grattoni	31
10	Drug Delivery: Sustained Zero‐Order Release of Intact Ultra‐Stable Drug‐Loaded Liposomes from an Implantable Nanochannel Delivery System (Adv. Healthcare Mater. 2/2014) 2014 ·Advanced Healthcare Materials ·Christian Celia, Silvia Ferrati, Shyam S. Bansal, Anne L. van de Ven, Barbara Ruozi, Erika Zabre, Sharath Hosali, Donatella Paolino, Maria Grazia Sarpietro, Daniel H. Fine, Massimo Fresta, Mauro Ferrari, Alessandro Grattoni	1
11	Sustained Zero‐Order Release of Intact Ultra‐Stable Drug‐Loaded Liposomes from an Implantable Nanochannel Delivery System 2013 ·Advanced Healthcare Materials ·Christian Celia, Silvia Ferrati, Shyam S. Bansal, Anne L. van de Ven, Barbara Ruozi, Erika Zabre, Sharath Hosali, Donatella Paolino, Maria Grazia Sarpietro, Daniel H. Fine, Massimo Fresta, Mauro Ferrari, Alessandro Grattoni	46
12	Leveraging nanochannels for universal, zero-order drug delivery in vivo 2013 ·Journal of Controlled Release ·Silvia Ferrati, Daniel H. Fine, Junping You, Enrica De Rosa, Hudson Lee, Erika Zabre, Sharath Hosali, Li Zhang, (unknown), Shyam S. Bansal, Andrea M. Cordero‐Reyes, (unknown), (unknown), (unknown), Ganesh S. Palapattu, Małgorzata Kloc, Rafik M. Ghobrial, Mauro Ferrari, Alessandro Grattoni	70
13	Characterization of a nanogland for the autotransplantation of human pancreatic islets 2013 ·Lab on a Chip ·Omaima M. Sabek, Silvia Ferrati, Daniel Fraga, (unknown), Erika Zabre, Daniel H. Fine, Mauro Ferrari, A. Osama Gaber, Alessandro Grattoni	47
14	Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations 2013 ·Current Drug Targets ·Shyam S. Bansal, Christian Celia, Silvia Ferrati, Erika Zabre, Mauro Ferrari, Ganesh S. Palapattu, Alessandro Grattoni	7
15	Inter‐endothelial Transport of Microvectors using Cellular Shuttles and Tunneling Nanotubes 2012 ·Small ·Silvia Ferrati, (unknown), Huw D. Summers, Paul Rees, (unknown), (unknown), Xuewu Liu, Stephen T.C. Wong, Andrew J. Bean, Mauro Ferrari, Rita E. Serda	25
16	Logic‐Embedded Vectors for Intracellular Partitioning, Endosomal Escape, and Exocytosis of Nanoparticles 2010 ·Small ·Rita E. Serda, Aaron Mack, Anne L. van de Ven, Silvia Ferrati, Kenneth Dunner, Biana Godin, Ciro Chiappini, Matthew Landry, Louis Brousseau, Xuewu Liu, Andrew J. Bean, Mauro Ferrari	84
17	Intracellular trafficking of silicon particles and logic-embedded vectors 2010 ·Nanoscale ·Silvia Ferrati, Aaron Mack, Ciro Chiappini, Xuewu Liu, Andrew J. Bean, Mauro Ferrari, Rita E. Serda	44
18	Intracellular Trafficking of Nano-Carriers 2010 ·Silvia Ferrati, Rita E. Serda, Andrew J. Bean, Mauro Ferrari	1
19	Mitotic trafficking of silicon microparticles 2009 ·Nanoscale ·Rita E. Serda, Silvia Ferrati, Biana Godin, Ennio Tasciotti, (unknown), Mauro Ferrari	69
20	A new organogelator based on an enantiopure C2 symmetric pyrrolidine 2007 ·Chemical Communications ·Stefano Cicchi, Giacomo Ghini, Luisa Lascialfari, Alberto Brandi, (unknown), Debora Berti, Silvia Ferrati, Piero Baglioni	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact